6分钟步行测试的变化是慢性心力衰竭死亡的独立预测因子,心力衰竭的预测因子是慢性心力衰竭的死亡因子,心力衰竭的预测因子是慢性心力衰竭的死亡因子
Peder L Myhre1,2, Øyunn Kleiven3, Kristian Berge1,2
1Division of Medicine, Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
European journal of heart failure
|July 26, 2024
概括
对于心力衰竭患者的6分钟步行测试 (6MWT) 的改善与减少喷射率 (HFrEF) 患者的生存率增加相关. 这种6MWT变化是预后的可靠指标,也是临床试验中潜在的替代结果.
科学领域:
- 心脏病学和心血管疾病.
- 临床试验和结果研究研究
- 疾病中的运动生理学
背景情况:
- 功能能力对于评估心力衰竭与减少喷射率 (HFrEF) 是至关重要的.
- 6分钟步行测试 (6MWT) 是HFrEF中功能能力和风险分层的实际测量.
- 作为HFrEF试验中替代结果的6MWT变化的预后值需要进一步澄清.
研究的目的:
- 为了评估6分钟步行测试 (6MWT) 性能变化的预后意义.
- 评估6MWT改善与HFrEF患者死亡风险之间的关联.
- 确定6MWT变化是否可以在心力衰竭临床试验中作为有效的替代结果.
主要方法:
- 在挪威的HF门诊中对3636名HFrEF患者进行前性队列研究.
- 6MWT在基线和治疗优化后进行;通过考克斯回归评估死亡率.
- 分析包括绝对和相对6MWT变化,对NYHA类和NT-proBNP进行调整.
主要成果:
- 平均6MWT改善了40m的治疗后优化,其中38%显示改善了NYHA类.
- 更大的6MWT改善与更好的NYHA类和降低的NT-proBNP水平相关.
- 6MWT增加50m与死亡风险降低17% (aHR为0.84),独立于其他因素.
结论:
- 在HFrEF患者中,6MWT的改善与延长的生存率显著相关.
- 6MWT改善的预后值独立于NT-proBNP和NYHA类的变化.
- 这些发现支持使用6MWT变化作为心力衰竭研究中的替代结果指标.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...